API Holdings, PharmEasy’s parent, has repaid ₹1,050 crore in term debt, but it has not announced an IPO. Management is weighing two options—an independent API Holdings listing or a merger with its listed diagnostics business, Thyrocare—and says it will decide after targeting profitability in the business excluding Thyrocare by September 2027.
What has changed at API Holdings
Moneycontrol reported on October 5, 2026, that API Holdings repaid ₹1,050 crore of outstanding term debt using proceeds from a partial sale of its Thyrocare stake and internal accruals. It retained a 51.02% controlling stake in Thyrocare. Moneycontrol’s report is the source for these figures.
As an Amazon Associate I earn from qualifying purchases.
The debt repayment is a meaningful balance-sheet development, but it does not by itself establish that every part of the group is debt-free. The report describes the repayment of term debt; a detailed reconciliation of other liabilities and cash is not established in the available reporting. API Holdings’ financial reports page lists company materials, but the underlying statements have not been reviewed here.
Recommended Free Tools
Profitability depends on which part of the group you mean
The consolidated group, including Thyrocare, is reported as already profitable. API Holdings’ target is different: profitability for its business excluding Thyrocare by September 2027. That distinction means group-level profitability should not be read as proof that PharmEasy or the standalone parent has already reached that milestone.
#1 Best Overall
- Clinically Accurate: Easy Operation by two buttons, Advanced Accuracy, No Calibration required.
- Large Multi-Color Backlit Display: The large, oversized numbers make reading the results from this upper arm blood pressure monitoring device a breeze. Coded (GREEN/YELLOW/RED) display tells if your blood pressure readings are optimal or not.
- Easy Management: Manage and track up to 99 readings on your blood pressure monitor and unlimited readings on your smartphone with iHealth's free iOS and Android applications ( iOS 12.0 or later. Android 9.0 or later.Requires Bluetooth 4.0.and up).
- Heart Rhythm Disturbances: This unit automatically identifies and alerts you to any heart rhythm disturbances. If detected, a warning symbol will be displayed after the measurement is taken.
- What You Get: 1 x blood pressure monitor that meets ESH 2010 performance standards, 4 AAA batteries, 1 wide range cuff that fits upper arms with Circumference of 8.7"-16.5" (22-42cm),1 Instruction manual, our worry-free 12-month warranty and friendly California-based customer service.
Moneycontrol reported that losses for the business excluding Thyrocare narrowed from ₹637 crore in FY24 to ₹396 crore in FY25 and ₹168 crore in FY26. It also reported operating expenses of ₹1,225 crore, ₹1,029 crore and ₹943 crore in those fiscal years, respectively. These are figures attributed to the outlet, not independently reconciled here.
The company is also targeting annual revenue growth of around 15%, according to the same report; that is a plan, not a guaranteed result. Moneycontrol said around 25% of PharmEasy revenue comes from higher-margin products and services, while about 9% comes from generics and private-label products.
Rank #2
- LARGE EASY-TO-READ DISPLAY: Bright screen clearly shows SpO2, pulse rate, and signal strength with large digits. The waveform bar graph provides visual confirmation of pulse strength, making it ideal for adults and users who prefer clear visibility.
- PORTABLE & USER-FRIENDLY: Compact, lightweight design fits easily in your pocket or bag. One-button operation makes it simple for anyone to use—just insert your finger and press the button for instant results. Auto power-off preserves battery life.
- PERFECT FOR EVERYDAY & OUTDOOR USE: Great for checking oxygen and pulse levels at home, during workouts, hiking, skiing, or high-altitude trips. A practical tool for fitness lovers, outdoor enthusiasts, and anyone who wants to keep an eye on their daily wellness.
- COMPLETE PACKAGE INCLUDED: Comes with 1x Pulse Oximeter, 2x AAA Batteries , 1x Lanyard for easy carrying, and 1x Instruction Manual. Ready to use right out of the box—no additional purchases needed.
IPO or Thyrocare merger: the two reported options
API Holdings managing director and CEO Rahul Guha said the path remains undecided: “It is too premature to say what path the company will take,” he told Moneycontrol. The two options reported are an independent IPO of API Holdings or a potential merger with Thyrocare.
Free tools Windows power users keep installed
One-click scans. No signup required.
| Option | What it would mean | What is known about timing |
|---|---|---|
| Independent API Holdings IPO | API Holdings would pursue a standalone public listing rather than combine with Thyrocare. The report does not state the issue structure, size, valuation or other terms. | Management says it will decide after reaching its profitability target; no timetable or new offer filing is reported. |
| Merger with Thyrocare | The businesses could be combined with Thyrocare, which is already listed. The report does not state a proposed deal structure, exchange ratio or transaction terms. | No transaction timetable is reported. Management’s decision is tied to the profitability milestone. |
Guha said he would not rush an IPO simply to take advantage of favorable market conditions. That is a management statement, not a board-approved timetable or evidence that either route has been selected. The report does not establish which option is more likely or more valuable; either route would require its own transaction and regulatory steps.
Rank #3
- Simple to Use Without a Subscription: No Bluetooth, Wi-Fi, cords or PC needed. Place the device near your smartphone. Monitor your heart by placing your fingers or thumbs on the silver KardiaMobile EKG sensors. Know in 30 seconds whether your heart rhythm is normal.
Guha also described the company’s strategy this way: “We are no longer a medicine delivery platform; we are an OPD healthcare platform.” That is management’s characterization of the business, not independent verification of its performance or the success of that strategy.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What the earlier IPO filing does—and does not—show
API Holdings did file IPO draft papers in the past. The Securities and Exchange Board of India’s public-issues record lists “API Holdings Limited IPO – DRHP,” dated November 11, 2021: SEBI’s filing record.
Rank #4
- Convenient Dual User Mode: Store up to 240 readings for two users, allowing easy tracking and comparison of measurements
- Fast and Accurate Measurements: Our fully automatic wrist blood pressure machine provides fast and precise results, simply press the "START/STOP" button, and the measurement process takes 35 seconds; the device automatically turns off after 60 seconds of inactivity
- Voice Broadcast Design: Our automatic blood pressure cuff features a voice broadcast function, making it ideal for individuals with poor eyesight; you can adjust the volume or turn off the sound using the SET and MEM buttons
- Large LED Backlit Display: The large LED screen of our blood pressure monitor features clear numbers, ensuring easy readability even in low-light conditions, enjoy a hassle-free visual experience
- Portable Rechargeable Blood Pressure Monitor: Equipped with a built-in rechargeable battery and Type-C cable for convenient charging anytime, eliminating the need for battery replacements and ensuring you can easily monitor your health (Note: Charging adapter not included in the packaging)
That historical record is not a current offer. Moneycontrol’s October 2026 report describes a possible future return to public markets, but does not report a newly filed DRHP, a listing date, an issue size or pricing. Guha said: “My mission is to take a great company to IPO, and for that I need to be profitable.” His comment explains the profitability priority; it does not amount to an IPO announcement.
Quick Recap
Best Value
- ACCURATE AND DETAILED EKG RESULTS. KardiaMobile 6L records a medical-grade, six-lead EKG and provides FDA-cleared determinations of your heart rhythm in just 30 seconds.
- SIX LEADS, SIX TIMES THE DATA. Six-lead EKGs give you a more detailed view of your heart and more data to share with your doctor. With KardiaMobile 6L, you can detect AFib, Bradycardia, Tachycardia and Normal Sinus Rhythm right on your smartphone.
- TRUSTED BY PROFESSIONALS: Recommended by doctors, KardiaMobile 6L is the world’s first FDA-cleared six-lead personal EKG
- COMPATIBLE WITH SMARTPHONES. Works with most smartphones and tablets. KardiaMobile 6L is compatible with most popular phones and tablets. To use your Kardia device, you must download the Kardia app on a compatible device. Visit the Kardia store to check the list of compatible devices.
- NO SUBSCRIPTION REQUIRED. Takes a six-lead EKG and detects Atrial Fibrillation, Bradycardia, Tachycardia, and Normal Sinus Rhythm without a KardiaCare subscription.
What to watch next
- Whether API Holdings reaches its stated September 2027 profitability target for the business excluding Thyrocare.
- Whether the company formally selects a standalone listing or a Thyrocare merger after that milestone.
- Whether a new offer document or formal transaction proposal is filed. The historical 2021 DRHP is not evidence of a new filing.
- More detailed financial disclosures that clarify debt, cash and profitability by business segment.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
